share_log

Aytu BioPharma | 8-K: Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

SEC ·  Sep 26 16:37
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more